ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 332

Incident Gout After Renal Transplantation in Gout-naïve Patients: Large Database Analysis

Brian LaMoreaux1, Megan Francis-Sedlak 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: gout, Kidney, transplantation and renal disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients undergoing kidney transplantation are at increased risk for developing hyperuricemia and gout compared to the general population (generally attributed to the frequent use of calcineurin inhibitors, cyclosporine and tacrolimus). However, the proportion of renal transplant patients that develop gout and the timing in which this occurs post-transplant is less established. This study sought to describe and quantify the incidence of gout in gout-naïve patients undergoing renal transplantation.

Methods: This retrospective analysis of Humana Research Database 2007-2017 claims data (private insurance and Medicare) was performed by identifying kidney transplant patients who were in plan for at least 6 months before and 5 years after transplant. Only patients without an ICD-9/10 gout diagnostic code within 6-months prior to transplant were included. Included patients were then examined for cumulative incidence of gout post-transplant.

Results: The database contained 16,454 patients that underwent kidney transplant. Of these, 920 patients underwent renal transplant, were in plan for at least 6 months before and 5 years after transplant, and did not have a gout diagnostic code before transplant. Of these, 212 patients (23%) had a post-transplant gout code while in plan, and 175 (19%) developed gout within 5 years post-transplant. The proportion of patients with gout progressively increased over time post-transplant and did not plateau. (Figure 1)

Conclusion: Gout is a known frequent comorbidity in solid organ transplant patients, but the timing and proportion of transplant patients who develop gout is not well described. Using a large database analysis, this analysis showed that the proportion of gout-naïve patients undergoing kidney transplantation who develop gout is high and that this proportion only increases as patients are followed over a longer period of time.

Figure 1. Proportion of gout-naïve kidney transplant patients who developed gout over 5 years post-transplant


Disclosure: B. LaMoreaux, Horizon, 3, 4; M. Francis-Sedlak, Horizon, 3, 4, Horizon Therapeutics, 3, 4; R. Holt, Horizon, 3, 4, Horizon Therapeutics, 3, 4.

To cite this abstract in AMA style:

LaMoreaux B, Francis-Sedlak M, Holt R. Incident Gout After Renal Transplantation in Gout-naïve Patients: Large Database Analysis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/incident-gout-after-renal-transplantation-in-gout-naive-patients-large-database-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incident-gout-after-renal-transplantation-in-gout-naive-patients-large-database-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology